Esophageal Cooling for Hypoxic Ischemic Encephalopathy: A Feasibility Study.

Area of Science:

• Critical Care Medicine
• Cardiovascular Research
• Neurology

Background:

• Targeted temperature management (TTM) is crucial for improving outcomes in hypoxic ischemic encephalopathy.
• Esophageal cooling devices (ECDs) show promise in animal models, but human data are limited.
• ECDs may offer benefits similar to intravascular cooling with potentially reduced patient risk.

Purpose of the Study:

• To evaluate the efficacy of an esophageal cooling device (ECD) as a substitute for intravascular cooling catheters in achieving TTM post-cardiac arrest.
• To assess the performance of ECD in terms of insertion, temperature achievement, and maintenance.

Main Methods:

• Prospective study enrolling nine intensive care unit patients requiring TTM after cardiac arrest.
• Primary outcomes included insertion timeliness, ease of use, user ratings, time to reach 36°C, and temperature stability over 24 hours.
• Comparison of ECD performance against established intravascular and external cooling methods.

Main Results:

• Time to reach target temperature ranged from 0 to 540 minutes (mean 113.33 min).
• Target temperature (36°C ± 1°C) was maintained for a mean of 91.67% of the 24-hour period.
• User evaluations indicated a preference for ECD over intravascular cooling and positive overall usability.

Conclusions:

• Esophageal cooling devices can adequately achieve and maintain targeted temperature management goals in post-cardiac arrest patients.
• ECD represents a potentially safer and effective alternative to intravascular cooling methods.
• User feedback suggests favorable acceptance and usability of the ECD.